Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4235357

CCC(CC)NC(=O)Nc1ccc(Oc2ccc(N)c(OC)c2)cc1.N

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.63
TAS1R3 Q7RTX0 1/20 0.57
TAS1R1 Q7RTX1 1/20 0.57
MTNR1B P49286 7/20 0.47
BRAF P15056 3/20 0.46
HDAC1 Q13547 3/20 0.46
RAF1 P04049 1/20 0.46
ARAF P10398 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MTNR1A P48039 4/20 0.44
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42
HDAC7 Q8WUI4 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC10 Q969S8 2/20 0.42
HDAC11 Q96DB2 2/20 0.42
HDAC8 Q9BY41 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4236682 0.99 PKM (0.64) PKMTAS1R3TAS1R1MTNR1BBRAF
SCHEMBL4228568 0.86 MAPK1 (0.50) PKMMTNR1BBRAFHDAC1RAF1
SCHEMBL4233255 0.84 PKM (0.59) PKMTAS1R3TAS1R1MTNR1BBRAF
SCHEMBL4229275 0.82 PKM (0.63) PKMTAS1R3TAS1R1MTNR1BCYP2C9
SCHEMBL4227928 0.81 PKM (0.69) PKMTAS1R3TAS1R1MTNR1BCYP2C9
SCHEMBL12593832 0.81 AAK1 (0.48) TAS1R3TAS1R1MTNR1BBRAFHDAC1
SCHEMBL4788024 0.81 PKM (0.59) PKMTAS1R3TAS1R1MTNR1BRAF1
SCHEMBL4689054 0.81 TAS1R3 (0.72) PKMTAS1R3TAS1R1MTNR1BRAF1
Ammonia Solution, Strong SCHEMBL4235457 0.81 PKM (0.58) PKMTAS1R3TAS1R1MTNR1BALDH1A1
SCHEMBL4235362 0.80 TAS1R3 (0.46) PKMTAS1R3TAS1R1MTNR1BBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233910-A1 Npy antagonists, preparation and uses NPY1R, NPY5R, NPY2R PKM 1734/4885TAS1R3 1436/4885TAS1R1 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.